FindTrial
Sign In

Ondansetron versus lornoxicam intravenous regional anesthesia

Ondansetron versus lornoxicam as adjuvants to intravenous regional anesthesia (IVRA) in patients undergoing hand and forearm surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201608001744344
Enrollment
Unknown
Registered
2016-08-19
Start date
2016-06-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery anesthesia and postoperative pain

Interventions

control group ( C )
Ondansetron group ( O )
Lornoxicam group ( L )

Sponsors

Tanta University, Faculty of Medicine
Lead Sponsor
Department of anesthesia and surgical ICU
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: age 18 ¿ 60 years either gender ASA I-II undergoing hand and forearm surgeries

Exclusion criteria

Exclusion criteria: Patients with Raynaud disease sickle cell anaemia a history of any drug allergy

Design outcomes

Primary

MeasureTime frame
onset time of sensory and motor block;Tourniquet pain is assessed by visual Analogue Scale (VAS) ;Sensoryand motor recovery time—

Secondary

MeasureTime frame
total intra-operative fentanyl consumption;postoperative pain (VAS);The time of 1st analgesic requirement ;total consumption of pethidine;Intra-operative or postoperative complications ;Patient satisfaction—

Countries

Egypt

Contacts

Public ContactShaimaa Farouk

Lecturer of anesthesia and surgical ICU

Shaimaafarouk7777@yahoo.com01270440771

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026